Vaxart, Inc. — Earnings

Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR

Next earnings (estimated): Wed, April 1, 2026 29 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2025-12-31$104M↑+586.5%$24M24.8%
2025-09-30$72M↑+1367.9%$-8M↑+42.2%-10.8%
2025-06-30$40M↑+520.7%$-15M↑+9.0%-36.8%
2025-03-31$21M↑+857.2%$-16M↑+36.1%-71.5%
2024-12-31$15M↑+368.0%
2024-09-30$5M↑+134.8%$-14M↑+19.1%-293.4%
2024-06-30$6M↑+371.4%$-16M↑+27.0%-254.0%
2024-03-31$2M↑+223.1%$-24M↑+2.9%-1103.6%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2025 (Q4)

Revenue
$104M
↑+586.5% +$89M YoY
Net Income
$24M

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Go deeper